Publications

1. Zeiger JS, Lally SE, Dalvin LA, Shields CL. Advances in conjunctival melanoma: clinical features, diagnostic modalities, staging, genetic markers, and management. Can J Ophthalmol. 2023 Mar 12 [Epub ahead of print]
   View PubMed
2. Kaplan TM, Salomao DR, Dalvin LA. An Amelanotic Choroidal Lesion in a 68-Year-Old Man. JAMA Ophthalmol. 2023 Feb 1; 141 (2):206-207
   View PubMed
3. Guner MK, Ferenchak KT, Salomao DR, Dalvin LA. Simultaneous presentation of multifocal episcleral nodules and widespread systemic metastases following plaque radiotherapy of large choroidal melanoma. Can J Ophthalmol 2023 Jan 28 [Epub ahead of print]
   View PubMed
4. Dalvin LA, Pulido JS, Shields CL, Marchese A, Miserocchi E, Frenkel S, Pe'er J. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration. Eye (Lond). 2023 Jan; 37 (1):54-61 Epub 2022 Jan 09
   View PubMed
5. Shah SM, Boopathiraj N, Starr MR, Dalvin LA, AbouChehade J, Damento G, Garcia MD, Hodge DO, Bakri SJ, Sit AJ, Iezzi R. Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2022 Nov; 243:98-108. Epub 2022 Aug 03.
   View PubMed
6. Guner MK, Ferenchak K, Olsen TW, Dalvin LA. OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN CHOROIDAL MELANOMA-ASSOCIATED SUBRETINAL FLUID. Retina. 2022 Nov 1; 42 (11):2159-2168
   View PubMed
7. Magazin M, Dalvin LA, Salomao DR, Castner NB, Halbach C, Tooley AA. Sebaceous Carcinoma of the Eyelid: Proposed Nomenclature for Multifocal and Multicentric Disease. Ophthalmic Plast Reconstr Surg. 2022 Oct 20 [Epub ahead of print]
   View PubMed
8. Balasubramaniam SC, Dalvin LA, Bakri SJ. Prevalence of intraocular tumours detected by ultrasonography in eyes with opaque media. Can J Ophthalmol. 2022 Oct 14 [Epub ahead of print]
   View PubMed
9. Castillejo Becerra CM, Smith WM, Dalvin LA. Ophthalmic adverse effects of BRAF inhibitors. Eur J Ophthalmol. 2022 Oct 11; 11206721221132872 [Epub ahead of print]
   View PubMed
10. Starr MR, Dalvin LA, AbouChehade JE, Damento GM, Garcia M, Shah SM, Hodge DO, Iezzi R, Bakri SJ. Incidence of metformin use in patients with age-related macular degeneration versus normal controls: A population-based study in Olmsted County, Minnesota. Eye (Lond). 2022 Sep 23. [Epub ahead of print]
    View PubMed
11. Kasetty VM, Tran AQ, Rosenbaum PS, Dalvin LA, Tooley AA. Uveal melanoma presenting as panophthalmitis in the absence of an intraocular mass. Can J Ophthalmol 2022 Aug; 57 (4):e138-e140 Epub 2021 Oct 26
    View PubMed
12. Zhang HG, Dagliati A, Shakeri Hossein Abad Z, Xiong X, Bonzel CL, Xia Z, Tan BWQ, Avillach P, Brat GA, Hong C, Morris M, Visweswaran S, Patel LP, Gutierrez-Sacristan A, Hanauer DA, Holmes JH, Samayamuthu MJ, Bourgeois FT, L'Yi S, Maidlow SE, Moal B, Murphy SN, Strasser ZH, Neuraz A, Ngiam KY, Loh NHW, Omenn GS, Prunotto A, Dalvin LA, Klann JG, Schubert P, Vidorreta FJS, Benoit V, Verdy G, Kavuluru R, Estiri H, Luo Y, Malovini A, Tibollo V, Bellazzi R, Cho K, Ho YL, Tan ALM, Tan BWL, Gehlenborg N, Lozano-Zahonero S, Jouhet V, Chiovato L, Aronow BJ, Toh EMS, Wong WGS, Pizzimenti S, Wagholikar KB, Bucalo M, Cai T, South AM, Kohane IS, Weber GM, Consortium for Clinical Characterization of COVID-19 by EHR (4CE). International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit Med. 2022 Jun 29; 5 (1):81 Epub 2022 June 29
    View PubMed
13. Lally SE, Milman T, Orloff M, Dalvin LA, Eberhart CG, Heaphy CM, Rodriguez FJ, Lin CC, Dockery PW, Shields JA, Shields CL. Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients. Ophthalmology. 2022 Jun; 129 (6):679-693 Epub 2022 Jan 24
    View PubMed
14. Oyemade KA, Stafford SL, Gertz MA, Patel SV, Baratz KH, Dalvin LA. Intraocular plasmacytoma: A case of iris involvement and a review of the literature. Am J Ophthalmol Case Rep. 2022 Jun; 26:101533 Epub 2022 Apr 10
    View PubMed
15. Dalvin LA, Olsen TW, Bakri SJ, McCullough K, Tefferi A, Al-Kali A. Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy. Am J Ophthalmol Case Rep. 2022 Jun; 26:101554 Epub 2022 Apr 21
    View PubMed
16. Joseph AK, Guerin JB, Eckel LJ, Dalvin LA, Keating GF, Liebo GB, Benson JC, Brinjikji W, Laack NN, Silvera VM. Imaging Findings of Pediatric Orbital Masses and Tumor Mimics. Radiographics. 2022 May-Jun; 42 (3):880-897 Epub 2022 Mar 04
    View PubMed
17. Dominguez-Varela IA, Aguilera-Partida JA, Dalvin LA, Garza-Garza LA, Thompson-Garcia LM, Barbosa-Quintana A, Ancona-Lezama D. Retinoblastoma in an older Hispanic child masquerading as pars planitis: A case report. Eur J Ophthalmol. 2022 May; 32 (3):NP71-NP74 Epub 2021 Feb 10
    View PubMed
18. Oyemade KA, Xu TT, Lopez Dominguez J, Dumbrava MG, Hodge DO, White LJ, Dalvin LA. Population-based incidence of intraocular tumours in Olmsted County, Minnesota. Br J Ophthalmol. 2022 Apr 21 [Epub ahead of print]
    View PubMed
19. Parra-Bernal C, Aguilera-Partida JA, Dalvin LA, Rodriguez-Reyes AA, Ancona-Lezama D. Beneath the surface: a case report of metastatic iridociliary ring melanoma treated with pembrolizumab. Arq Bras Oftalmol 2022 Mar 21 [Epub ahead of print]
    View PubMed
20. Willett KL, Dalvin LA, Pritt BS, Fida M, Kasten MJ, Olsen TW. Cryptococcus gattii endogenous chorioretinitis. Am J Ophthalmol Case Rep. 2022 Mar; 25:101283 Epub 2022 Jan 20
    View PubMed
21. Dalvin LA, Deufel CL, Corbin KS, Petersen IA, Olsen TW, Roddy GW. Postradiation Optic Atrophy Is Associated With Intraocular Pressure and May Manifest With Neuroretinal Rim Thinning. J Neuroophthalmol. 2022 Mar 1; 42 (1):e159-e172 Epub 2021 Nov 11
    View PubMed
22. Pacheco RR, Yaghy A, Dalvin LA, Vaidya S, Perez AL, Lally SE, Shields JA, Shields CL. Conjunctival melanoma: outcomes based on tumour origin in 629 patients at a single ocular oncology centre. Eye (Lond). 2022 Mar; 36 (3):603-611 Epub 2021 Mar 26
    View PubMed
23. Fortes BH, Tailor PD, Dalvin LA. Correction to: Ocular Toxicity of Targeted Anticancer Agents. Drugs. 2022 Feb; 82 (3):355
    View PubMed
24. Ida CM, Pulido J, Greipp PT, Garcia JJ, Olsen TW, Dalvin L, Salomao DR. BAP1 Immunostain Status in Intraocular Biopsy Specimens for Uveal Melanoma Highly Correlates with Other Prognostic Markers. Ocul Oncol Pathol. 2022 Feb; 8 (1):22-29 Epub 2021 Nov 15
    View PubMed
25. Castillejo Becerra CM, Dalvin LA, Jevremovic D, Hodge DO, Tooley AA. Clinical characteristics and outcomes of ocular adnexal mantle cell lymphoma. Orbit. 2022 Feb; 41 (1):97-104 Epub 2022 Jan 04
    View PubMed
26. Witsberger EM, Dalvin LA, Patel SV. Visualizing Ocular Surface Squamous Neoplasia. Ophthalmology. 2022 Feb; 129 (2):146
    View PubMed
27. Peddada K, Dalvin LA, Mashayekhi A, Shields CL. DIAGNOSTIC CHALLENGES IN NECROTIC UVEAL MELANOMA. Retin Cases Brief Rep. 2022 Jan 1; 16 (1):92-94
    View PubMed
28. Fortes BH, Liou H, Dalvin LA. Ophthalmic adverse effects of taxanes: The Mayo Clinic experience. Eur J Ophthalmol. 2022 Jan; 32 (1):602-611 Epub 2020 Nov 04
    View PubMed
29. Claxton MR, Dalvin LA, Guo R, Tooley AA. Genetic Alterations in Melanocytoma Associated with Oculodermal Melanocytosis: Molecular Characteristics. Ophthalmic Plast Reconstr Surg. 2021 Dec 16 [Epub ahead of print]
    View PubMed
30. Fortes BH, Dalvin LA, Hogan WJ, Patnaik MM, Choong GM, Salomao DR, Barkmeier AJ, Bhatti MT. Isolated T-cell acute lymphoblastic leukemic optic disc infiltration. Am J Hematol. 2021 Dec 1; 96 (12):1717-1718 Epub 2021 Sept 30
    View PubMed
31. Deufel CL, Dalvin LA, Qian J, Vaishnav B, Cutsinger JM, Wittich MN, Petersen IA. How to design, fabricate, and validate a customized COMS-style eye plaque: Illustrated with a narrow-slotted plaque example. Brachytherapy. 2021 Nov-Dec; 20 (6):1235-1244 Epub 2021 July 01
    View PubMed
32. Dalvin LA, Sit AJ, Patel SV, Roddy GW. Preoperative testing for COVID-19 in an academic ophthalmology practice. J Cataract Refract Surg 2021 Nov 1; 47 (11):1483-1484
    View PubMed
33. Xu TT, Pulido JS, Parney IF, Ida CM, Dalvin LA, Olsen TW. Carbon Fiducial Markers for Tumor Localization in Stereotactic Irradiation of Uveal Melanoma. Ocul Oncol Pathol. 2021 Oct; 7 (5):368-375 Epub 2021 Aug 03
    View PubMed
34. Xu TT, Pulido JS, Deufel CL, Corbin KS, Petersen IA, Dalvin LA. Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma. Eye (Lond). 2021 Oct; 35 (10):2754-2762 Epub 2020 Nov 24
    View PubMed
35. Astafurov KV, Bothun ED, Laack NN, Deisher AJ, Patel SV, Dalvin LA. Ultra-low-dose (boom-boom) radiotherapy for management of recurrent ocular post-transplant lymphoproliferative disorder. Am J Ophthalmol Case Rep. 2021 Sep; 23:101118 Epub 2021 May 15
    View PubMed
36. Tanke LB, Leske DA, Dalvin LA. Conversion Factor for B-Scan Ultrasound Measurement of Intraocular Tumors With and Without the Sclera. J Ultrasound Med. 2021 Sep; 40 (9):1911-1917 Epub 2020 Dec 04
    View PubMed
37. Fortes BH, Liou H, Dalvin LA. Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience. Br J Ophthalmol. 2021 Sep; 105 (9):1263-1271 Epub 2020 Aug 23
    View PubMed
38. Vaidya S, Dalvin LA, Yaghy A, Pacheco R, Shields JA, Lally SE, Shields CL. Conjunctival melanoma: Risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center. Eur J Ophthalmol. 2021 Sep; 31 (5):2675-2685 Epub 2020 Nov 11
    View PubMed
39. Patel SV, Dalvin LA. Corneal Epitheliopathy Associated With Antibody-Drug Conjugates. Mayo Clin Proc. 2021 Jul; 96 (7):2001-2002
    View PubMed
40. Sweid A, El Naamani K, Sajja KC, Hammoud B, Knapp MD, Moylan DD, Joffe D, Morse CE, Habbal D, Weinberg JH, Tjoumakaris SI, Shields CL, Lezama DA, Lim LS, Dalvin LA, Rosenwasser R, Jabbour P. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. 2021 Jul; 13 (7):652-656 Epub 2020 Oct 29
    View PubMed
41. Shah SM, Barkmeier AJ, Dalvin LA, Tooley AA. Applicant Perceptions Regarding the 2020-2021 Virtual Ophthalmology Residency Interview and Match Season Journal of Academic Ophthalmology Journal of Academic Ophthalmology. 2021.
    
42. Fortes BH, Dalvin LA, Bakri SJ. Multimodal imaging of sclerochoroidal calcification associated with choroidal neovascular membrane. Can J Ophthalmol 2021 Jun; 56 (3):e98-e101 Epub 2020 Nov 26
    View PubMed
43. Dalvin LA, Pennington JD, Mashayekhi A, Shields CL. MULTIMODAL IMAGING OF MACULAR CHOROIDAL MACROVESSEL: A REPORT OF TWO CASES. Retin Cases Brief Rep. 2021 May 1; 15 (3):218-223
    View PubMed
44. Dalvin LA, Yaghy A, Vaidya S, Pacheco RR, Perez AL, Lally SE, Shields JA, Shields CL. Conjunctival Melanoma: Outcomes Based on Age at Presentation in 629 Patients at a Single Ocular Oncology Center. Cornea. 2021 May 1; 40 (5):554-563
    View PubMed
45. Fortes BH, Tailor PD, Dalvin LA. Ocular Toxicity of Targeted Anticancer Agents. Drugs. 2021 May; 81 (7):771-823 Epub 2021 Mar 31
    View PubMed
46. Xu TT, Moser JC, Dalvin LA. Uveal melanoma: laboratory advances and new frontiers in patient care. Curr Opin Ophthalmol. 2021 May 1; 32 (3):301-308
    View PubMed
47. Dominguez-Varela IA, Ancona-Lezama DA, Dalvin LA, Perez-Ramos EE. Choroidal melanoma treatment in times of coronavirus disease 2019. Melanoma Res 2021 Apr 1; 31 (2):194-195
    View PubMed
48. Ferenchak K, Dao LN, Dalvin LA. Ocular Relapse of B-Cell Acute Lymphoblastic Leukemia. JAMA Ophthalmol. 2021 Apr 1; 139 (4):e210514 Epub 2021 Apr 21
    View PubMed
49. Silvera VM, Guerin JB, Brinjikji W, Dalvin LA. Retinoblastoma: What the Neuroradiologist Needs to Know. AJNR Am J Neuroradiol. 2021 Apr; 42 (4):618-626 Epub 2021 Jan 28
    View PubMed
50. Shields CL, Constantinescu AB, Paulose SA, Yaghy A, Dalvin LA, Shields JA, Lally SE. Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration. Indian J Ophthalmol. 2021 Mar; 69 (3):563-567
    View PubMed
51. Yang X, Dalvin LA, Lim LS, Mashayekhi A, Shields JA, Shields CL. Ultra-low-dose (boom-boom) radiotherapy for choroidal lymphoma in three consecutive cases. Eur J Ophthalmol. 2021 Mar; 31 (2):NP91-NP96 Epub 2019 Nov 24
    View PubMed
52. Shields CL, Lally SE, Dalvin LA, Sagoo MS, Pellegrini M, Kaliki S, Gunduz AK, Furuta M, Mruthyunjaya P, Fung AT, Duker JS, Selig SM, Yaghy A, Ferenczy SR, Eydelman MB, Blumenkranz MS. White Paper on Ophthalmic Imaging for Choroidal Nevus Identification and Transformation into Melanoma. Transl Vis Sci Technol. 2021 Feb 5; 10 (2):24
    View PubMed
53. Mashayekhi A, Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Shields CL, Shields JA. ASSOCIATION OF VITREORETINAL LYMPHOMA WITH SYSTEMIC LYMPHOMA. Retina. 2021 Feb 1; 41 (2):259-265
    View PubMed
54. Yang X, Dalvin LA, Mazloumi M, Ferenczy S, Lim LS, Ancona-Lezama D, Shields JA, Mashayekhi A, Shields CL. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES. Retina. 2021 Feb 1; 41 (2):249-258
    View PubMed
55. Bas Z, Dalvin LA, Tadepalli S, Rao R, Shah A, Leahey AM, Shields CL. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients. Asia Pac J Ophthalmol (Phila). 2021 Jan 19; 10 (4):373-380
    View PubMed
56. Deufel CL, McCauley Cutsinger S, Corbin KS, Dalvin LA, Petersen IA. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for (125)I Collaborative Ocular Melanoma Study eye plaques. Brachytherapy. 2021 Jan-Feb; 20 (1):189-199 Epub 2020 Nov 10
    View PubMed
57. Shields CL, Yaghy A, Dalvin LA, Vaidya S, Pacheco RR, Perez AL, Lally SE, Shields JA. Conjunctival Melanoma: Outcomes based on the American Joint Committee on Cancer Clinical Classification (8th Edition) of 425 Patients at a Single Ocular Oncology Center. Asia Pac J Ophthalmol (Phila). 2020 Dec 9 Epub 2020 Dec 09
    View PubMed
58. Shields CL, Paulose SA, Yaghy A, Dalvin LA, Constantinescu AB, Lally SE, Shields JA. Ocular Surface Squamous Neoplasia Managed With Primary Interferon alpha2b: A Comparative Analysis of 212 Tumors in Smokers Versus Nonsmokers. Cornea. 2020 Dec 3 Epub 2020 Dec 03
    View PubMed
59. Yaghy A, Dalvin LA, Shields CL. A Hidden Pandemic. AMA J Ethics. 2020 Dec 1; 22 (12):E1067-1070 Epub 2020 Dec 01
    View PubMed
60. Iezzi LA, Dalvin LA. Optical Path Redirection Device for Optical Coherence Tomography Angiography of Recumbent Patients Under General Anesthesia. Transl Vis Sci Technol. 2020 Dec; 9 (13):45 Epub 2020 Dec 29
    View PubMed
61. Zhang HG, Moser JC, Dalvin LA. Characterization of uveal melanoma clinical trial design: a systematic review to establish an elusive standard of care. Acta Oncol. 2020 Nov; 59 (11):1401-1408 Epub 2020 July 01
    View PubMed
62. Ancona-Lezama D, Dalvin LA, Shields CL. Modern treatment of retinoblastoma: A 2020 review. Indian J Ophthalmol. 2020 Nov; 68 (11):2356-2365
    View PubMed
63. Sweid A, Hammoud B, Texakalidis P, Xu V, Shivashankar K, Baldassari MP, Das S, Tjoumakaris S, Shields CL, Ancona-Lezama D, Lim LS, Dalvin LA, Maamari DJ, Jabbour P. The Use of Alternative Routes for the Delivery of Intra-Arterial Chemotherapy for Retinoblastoma. Neurosurgery. 2020 Oct 15; 87 (5):956-963
    View PubMed
64. Mazloumi M, Dalvin LA, Abtahi SH, Yavari N, Yaghy A, Mashayekhi A, Shields JA, Shields CL. Photodynamic Therapy in Ocular Oncology. J Ophthalmic Vis Res. 2020 Oct-Dec; 15 (4):547-558 Epub 2020 Oct 25
    View PubMed
65. Yu MD, Dalvin LA, Shields CL. RETINAL CAVERNOUS HEMANGIOMA WITH INTRALESIONAL PHLEBOLITHS. Retin Cases Brief Rep. 2020 Fall; 14 (4):301-304
    View PubMed
66. Dalvin LA, Spaide RF, Yannuzzi LA, Freund KB, Pulido JS. HYDRATION FOLDS IN RHEGMATOGENOUS RETINAL DETACHMENT. Retin Cases Brief Rep. 2020 Fall; 14 (4):355-359
    View PubMed
67. Sweid A, Hammoud B, Weinberg JH, Texakalidis P, Xu V, Shivashankar K, Baldassari MP, Das S, Tjoumakaris SI, Shields CL, Lezama DA, Lim LS, Dalvin LA, El Naamani K, Jabbour P. Ophthalmic artery catheterization for retinoblastoma treatment: does reflux affect tumor response? J Neurointerv Surg. 2020 Sep; 12 (9):915-920 Epub 2020 Apr 09
    View PubMed
68. Yu MD, Dalvin LA, Ancona-Lezama D, Yaghy A, Ferenczy SR, Milman T, Eagle RC Jr, Shields CL. Choriocapillaris Compression Correlates with Choroidal Nevus-Associated Subretinal Fluid: OCT Analysis of 3431 Cases. Ophthalmology. 2020 Sep; 127 (9):1273-1276 Epub 2020 Mar 27
    View PubMed
69. Dalvin LA, Bas Z, Tadepalli S, Rao R, Vaidya S, Pacheco R, Shields CL. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. J Pediatr Ophthalmol Strabismus. 2020 Jul 1; 57 (4):224-234
    View PubMed
70. Sweid A, Hammoud B, Weinberg JH, Texakalidis P, Xu V, Shivashankar K, Baldassari MP, Das S, Ramesh S, Tjoumakaris S, Shields CL, Ancona-Lezama D, Lim LS, Dalvin LA, Jabbour P. Intra-Arterial Chemotherapy for Retinoblastoma in Infants View PubMed
71. Yang X, Dalvin LA, Mazloumi M, Chang M, Shields JA, Mashayekhi A, Shields CL. Impact of uveal melanoma thickness on post-plaque radiotherapy outcomes in the prophylactic anti-vascular endothelial growth factor era in 1131 patients. Clin Exp Ophthalmol. 2020 Jul; 48 (5):610-623 Epub 2020 Apr 28
    View PubMed
72. Yaghy A, Yu MD, Dalvin LA, Mazloumi M, Ferenczy SR, Shields CL. Photoreceptor morphology and correlation with subretinal fluid chronicity associated with choroidal nevus. Br J Ophthalmol. 2020 Jun; 104 (6):863-867 Epub 2019 Sept 18
    View PubMed
73. Mazloumi M, Dalvin LA, Ancona-Lezama D, Mashayekhi A, Shields CL. PHOTODYNAMIC THERAPY FOR EXTRAFOVEOLAR CHOROIDAL OSTEOMA. Retina. 2020 May; 40 (5):966-971
    View PubMed
74. Shah SM, Starr MR, Dalvin LA, Comfere NI, AbouChehade JE, Hodge DO, Iezzi R, Bakri SJ. INCREASED INCIDENCE OF CUTANEOUS KERATINOCYTIC AND MELANOCYTIC MALIGNANCIES IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION. Retina. 2020 May; 40(5):857-865.
    View PubMed
75. Dalvin LA, Zhang Q, Hamershock RA, Chang M, Yu MD, Mashayekhi A, Shields CL. Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients. Br J Ophthalmol. 2020 May; 104 (5):697-702 Epub 2019 Aug 13
    View PubMed
76. Vichitvejpaisal P, Dalvin LA, Lally SE, Shields CL. Delayed implant infection with Cutibacterium acnes (Propionibacterium acnes) 30 years after silicone sheet orbital floor implant. Orbit. 2020 Apr; 39 (2):139-142 Epub 2019 Apr 25
    View PubMed
77. Rihani HT, Dalvin LA, Hodge DO, Pulido JS. Incidence of Sturge-Weber syndrome and associated ocular involvement in Olmsted County, Minnesota, United States. Ophthalmic Genet. 2020 Apr; 41 (2):108-124 Epub 2020 Mar 31
    View PubMed
78. Shields CL, Yaghy A, Dalvin LA, Vaidya S, Pacheco RR, Perez AL, Ramesh S, George K, Arias DE, Shiuey EJ, Lally SE, Shields JA. Conjunctival Melanoma: Features and Outcomes Based on the Fitzpatrick Skin Type in 540 Patients at a Single Ocular Oncology Center. Ophthalmic Plast Reconstr Surg. 2020 Mar 2 Epub 2020 Mar 02
    View PubMed
79. Mazloumi M, Vichitvejpaisal P, Dalvin LA, Yaghy A, Ewens KG, Ganguly A, Shields CL. Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma. JAMA Ophthalmol. 2020 Mar 1; 138 (3):260-267
    View PubMed
80. Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Porcu P, Martinez NL, Glass J, Mashayekhi A, Shields CL. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center. Asia Pac J Ophthalmol (Phila). 2020 Mar-Apr; 9 (2):110-116
    View PubMed
81. Shields CL, Bas Z, Tadepalli S, Dalvin LA, Rao R, Schwendeman R, Lally SE, Shields JA, Shah A, Leahey A. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre. Br J Ophthalmol. 2020 Feb 12 [Epub ahead of print]
    View PubMed
82. Dalvin LA, Yu MD, Ancona-Lezama DA, Pulido JS, Olsen TW, Shields CL. Retinal haemangioblastoma associated with peripheral non-perfusion: widefield fluorescein angiography analysis of 41 cases. Br J Ophthalmol. 2020 Feb; 104 (2):167-172 Epub 2019 May 16
    View PubMed
83. Shields CL, Dalvin LA, Chang M, Mazloumi M, Fortin P, McGarrey M, Martin A, Yaghy A, Yang X, Vichitvejpaisal P, Mashayekhi A, Shields JA. Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals. JAMA Ophthalmol. 2020 Feb 1; 138 (2):136-146
    View PubMed
84. Chang M, Dalvin LA, Mazloumi M, Martin A, Yaghy A, Yang X, Bakhtiari S, Li L, Jennings E, Mashayekhi A, Shields CL. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age. Asia Pac J Ophthalmol (Phila). 2020 Jan-Feb; 9 (1):29-38
    View PubMed
85. Shields CL, Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA. Circumscribed Choroidal Hemangioma: Visual Outcome in the Pre-Photodynamic Therapy Era versus Photodynamic Therapy Era in 458 Cases. Ophthalmol Retina. 2020 Jan; 4 (1):100-110 Epub 2019 Aug 22
    View PubMed
86. Dalvin LA, Hartnett ME, Bretz CA, Hann CR, Cui RZ, Marmorstein AD, Sheikh-Hamad D, Fautsch MP, Roddy GW. Stanniocalcin-1 is a Modifier of Oxygen-Induced Retinopathy Severity. Curr Eye Res. 2020 Jan; 45 (1):46-51 Epub 2019 Aug 28
    View PubMed
87. Ravindran K, Dalvin LA, Pulido JS, Brinjikji W. Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis. J Neurointerv Surg. 2019 Dec; 11 (12):1266-1272 Epub 2019 May 18
    View PubMed
88. Ancona-Lezama D, Dalvin LA, Lucio-Alvarez JA, Jabbour P, Shields CL. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments. Retina. 2019 Dec; 39 (12):2264-2272
    View PubMed
89. Lim LS, Dalvin LA, Ancona-Lezama D, Yu MD, Jabbour P, Shields CL. Retinoblastoma vascular perfusion and intra-arterial chemotherapy cycle requirements. Clin Exp Ophthalmol. 2019 Dec; 47 (9):1164-1172 Epub 2019 Sept 04
    View PubMed
90. Shields CL, Dalvin LA, Vichitvejpaisal P, Mazloumi M, Ganguly A, Shields JA. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review. Indian J Ophthalmol. 2019 Dec; 67 (12):1959-1963
    View PubMed
91. Camp DA, Dalvin LA, Schwendeman R, Lim LS, Shields CL. Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras. Indian J Ophthalmol. 2019 Dec; 67 (12):1997-2004
    View PubMed
92. Marous CL, Shields CL, Yu MD, Dalvin LA, Ancona-Lezama D, Shields JA. Malignant transformation of choroidal nevus according to race in 3334 consecutive patients. Indian J Ophthalmol. 2019 Dec; 67 (12):2035-2042
    View PubMed
93. Battiston AJ, Dalvin LA, Shields CL. Neurofibromatosis type-1 with retinal microvascular corkscrew tortuosity. Indian J Ophthalmol. 2019 Dec; 67 (12):2054-2055
    View PubMed
94. Dalvin LA, Mashayekhi A, Shields CL. Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma. JAMA Ophthalmol 2019 Dec 1; 137 (12):1466
    View PubMed
95. Chang M, Lally SE, Dalvin LA, Orloff MM, Shields CL. Conjunctival melanoma with orbital invasion and liver metastasis managed with systemic immune checkpoint inhibitor therapy. Indian J Ophthalmol. 2019 Dec; 67 (12):2071-2073
    View PubMed
96. Yu MD, Dalvin LA, Shields CL. Optical Coherence Tomography Monitoring in a Patient With Retinoblastoma. JAMA Ophthalmol. 2019 Nov 1; 137 (11):e186243 Epub 2019 Nov 14
    View PubMed
97. Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Mashayekhi A, Shields CL. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center. Ophthalmol Retina. 2019 Nov; 3 (11):998-1005 Epub 2019 May 29
    View PubMed
98. Dalvin LA, Shields CL, Ancona-Lezama DA, Yu MD, Di Nicola M, Williams BK Jr, Lucio-Alvarez JA, Ang SM, Maloney SM, Welch RJ, Shields JA. Combination of multimodal imaging features predictive of choroidal nevus transformation into melanoma. Br J Ophthalmol. 2019 Oct; 103 (10):1441-1447 Epub 2018 Dec 06
    View PubMed
99. Shields CL, Dalvin LA, Yu MD, Ancona-Lezama D, Di Nicola M, Williams BK, Lucio-Alvarez JA, Ang SM, Maloney SM, Welch RJ, Shields JA. CHOROIDAL NEVUS TRANSFORMATION INTO MELANOMA PER MILLIMETER INCREMENT IN THICKNESS USING MULTIMODAL IMAGING IN 2355 CASES: The 2019 Wendell L. Hughes Lecture. Retina 2019 Oct; 39 (10):1852-1860
    View PubMed
100. Vichitvejpaisal P, Dalvin LA, Mazloumi M, Ewens KG, Ganguly A, Shields CL. Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D. Ophthalmology. 2019 Oct; 126 (10):1445-1453 Epub 2019 Apr 24
     View PubMed
101. Udyaver S, Dalvin LA, Lim LS, Mazloumi M, Atalay HT, Khoo CTL, Shields JA, Shields CL. Predictors of enucleation in Coats disease: analysis of 259 eyes of 259 patients at a single center. J AAPOS. 2019 Oct; 23 (5):266.e1-266.e9 Epub 2019 Sept 12
     View PubMed
102. Dalvin LA, Udyaver S, Lim LS, Mazloumi M, Atalay HT, Khoo CTL, Shields CL. Coats Disease: Clinical Features and Outcomes by Age Category in 351 Cases. J Pediatr Ophthalmol Strabismus. 2019 Sep 1; 56 (5):288-296
     View PubMed
103. Khoo CTL, Dalvin LA, Lim LS, Mazloumi M, Atalay HT, Udyaver S, Shields JA, Shields CL. Factors Predictive of Subretinal Fluid Resolution in Coats Disease: Analysis of 177 Eyes in 177 Patients at a Single Center. Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug; 8 (4):290-297
     View PubMed
104. Damento GM, Pulido JS, Abbott BA, Hodge DO, Dalvin LA. TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma. Mayo Clin Proc. 2019 Jul; 94 (7):1287-1295
     View PubMed
105. Masoomian B, Dalvin LA, Yu MD, Stathopoulos C, Shields CL. Retinoblastoma in older patients: A retrospective comparative analysis of 100 consecutive patients based on age. Saudi J Ophthalmol. 2019 Jul-Sep; 33 (3):243-250 Epub 2019 Aug 27
     View PubMed
106. Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA, Shields CL. Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases. Saudi J Ophthalmol. 2019 Jul-Sep; 33 (3):219-228 Epub 2019 July 16
     View PubMed
107. Shields CL, Udyaver S, Dalvin LA, Lim LS, Atalay HT, Khoo C, Mazloumi M, Shields JA. Visual acuity outcomes in Coats disease by classification stage in 160 patients. Br J Ophthalmol. 2019 Jun 8 Epub 2019 June 08
     View PubMed
108. Yaghy AN, Dalvin LA, Shields CL. Retinal elevation in an infant. Indian J Ophthalmol. 2019 Jun; 67 (6):725
     View PubMed
109. Shields CL, Udyaver S, Dalvin LA, Lim LS, Atalay HT, L Khoo CT, Mazloumi M, Shields JA. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center. Indian J Ophthalmol. 2019 Jun; 67 (6):772-783
     View PubMed
110. Yu MD, Dalvin LA, Welch RJ, Shields CL. Precision Intravitreal Chemotherapy for Localized Vitreous Seeding of Retinoblastoma. Ocul Oncol Pathol. 2019 Jun; 5 (4):284-289 Epub 2018 Sept 13
     View PubMed
111. Shields CL, Lim LS, Dalvin LA, Shields JA. Small choroidal melanoma: detection with multimodal imaging and management with plaque radiotherapy or AU-011 nanoparticle therapy. Curr Opin Ophthalmol. 2019 May; 30 (3):206-214
     View PubMed
112. Dalvin LA, Starr MR, AbouChehade JE, Damento GM, Garcia M, Shah SM, Hodge DO, Meissner I, Bakri SJ, Iezzi R. Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration. JAMA Ophthalmol. 2019 May 01; 137(5):483-490.
     View PubMed
113. Starr MR, Dalvin LA, AbouChehade JE, Damento GM, Garcia MD, Shah SM, Hodge DO, Meissner I, Iezzi R, Bakri SJ. Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmic Surg Lasers Imaging Retina. 2019 May 01; 50(5):e140-e157.
     View PubMed
114. Sivalingam MD, Dalvin LA, Shields CL, Mashayekhi A, Shields JA. Amelanotic Ciliochoroidal Melanoma in a Patient with Oculocutaneous Albinism. Ocul Oncol Pathol. 2019 Apr; 5 (3):182-185 Epub 2018 Sept 03
     View PubMed
115. Ancona-Lezama DA, Dalvin LA, Lucio-Alvarez JA, Jabbour P, Shields CL. Choroidal Ischemia Sparing the Watershed Zone following Intra-Arterial Chemotherapy for Retinoblastoma. Ocul Oncol Pathol. 2019 Apr; 5 (3):190-194 Epub 2018 Sept 17
     View PubMed
116. Dalvin LA, Maxfield SD, Salomao DR, Pulido JS. Presumed Choroidal Granuloma Annulare Mimicking Choroidal Lymphoma. Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1; 50 (4):e128-e132
     View PubMed
117. Gervasio KA, Dalvin LA, Shields CL. Spontaneous Regression of Florid Retinal Neovascularization Following Resolution of Traction Retinal Detachment in an Eye With Treated Retinoblastoma. J Pediatr Ophthalmol Strabismus. 2019 Mar 25; 56:e24-e27
     View PubMed
118. Camp DA, Yadav P, Dalvin LA, Shields CL. Glaucoma secondary to intraocular tumors: mechanisms and management. Curr Opin Ophthalmol. 2019 Mar; 30 (2):71-81
     View PubMed
119. Li L, Dalvin LA, Shields CL. Atypical Fundus Mass in a Child. JAMA Ophthalmol. 2019 Mar 1; 137 (3):322-323
     View PubMed
120. D'Costa MR, Dalvin LA, Manohar S, Maguire LJ, Grande JP, Gonsalves WI, Nasr SH, Hogan MC. Crystalglobulin-Induced Nephropathy and Keratopathy. Kidney Med. 2019 Mar-Apr; 1 (2):71-74 Epub 2019 Feb 25
     View PubMed
121. Li MM, Dalvin LA, Shields CL. Coexisting White and Dark Without Pressure Abnormalities Surrounding Congenital Hypertrophy of the Retinal Pigment Epithelium. J Pediatr Ophthalmol Strabismus. 2019 Feb 8; 56:e5-e7 Epub 2019 Feb 08
     View PubMed
122. Dalvin LA, Kumari M, Essuman VA, Shohelly Shipa S, Ancona-Lezama D, Lucio-Alvarez JA, Jabbour P, Shields CL. Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of Experience. Ocul Oncol Pathol. 2019 Feb; 5 (2):139-146 Epub 2018 Aug 21
     View PubMed
123. Ang SM, Dalvin LA, Emrich J, Komarnicky L, Shields JA, Shields CL. Plaque Radiotherapy for Medulloepithelioma in 6 Cases From a Single Center. Asia Pac J Ophthalmol (Phila). 2019 Jan-Feb; 8 (1):30-35 Epub 2018 Oct 30
     View PubMed
124. Ghassemi F, Khojasteh H, Khodabande A, Dalvin LA, Mazloumi M, Riazi-Esfahani H, Mirghorbani M. Comparison of Three Different Techniques of Inverted Internal Limiting Membrane Flap in Treatment of Large Idiopathic Full-Thickness Macular Hole. Clin Ophthalmol. 2019; 13:2599-2606 Epub 2019 Dec 27
     View PubMed
125. Shields CL, Dalvin LA, Ancona-Lezama D, Yu MD, Di Nicola M, Williams BK Jr, Lucio-Alvarez JA, Ang SM, Maloney S, Welch RJ, Shields JA. CHOROIDAL NEVUS IMAGING FEATURES IN 3,806 CASES AND RISK FACTORS FOR TRANSFORMATION INTO MELANOMA IN 2,355 CASES: The 2020 Taylor R. Smith and Victor T. Curtin Lecture. Retina. 2018 Dec 31 [Epub ahead of print]
     View PubMed
126. Dalvin LA, Pulido JS, Shields CL. Clarification on Uveal Melanoma Associated With Myotonic Dystrophy-Reply. JAMA Ophthalmol 2018 Dec 1; 136 (12):1427
     View PubMed
127. Dalvin LA, Salomao DR, Patel SV. Population-based incidence of conjunctival tumours in Olmsted County, Minnesota. Br J Ophthalmol. 2018 Dec; 102 (12):1728-1734 Epub 2018 Mar 06
     View PubMed
128. Dalvin LA, Ancona-Lezama D, Lucio-Alvarez JA, Masoomian B, Jabbour P, Shields CL. Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras. Ophthalmology. 2018 Nov; 125 (11):1803-1811 Epub 2018 June 18
     View PubMed
129. Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects. Retina. 2018 Jun; 38 (6):1063-1078
     View PubMed
130. Dalvin LA, Shields CL, Pulido JS, Sioufi K, Cohen V, Shields JA. Uveal Melanoma Associated With Myotonic Dystrophy: A Report of 6 Cases. JAMA Ophthalmol. 2018 May 1; 136 (5):543-547
     View PubMed
131. Dalvin LA, Salomão DR, Iezzi R, Barkmeier AJ. Subconjunctival Exposure to Carbopol Causes Chronic Histiocytic Inflammatory Response in Rabbits. Transl Vis Sci Technol. 2018 May; 7(3):9. Epub 2018 May 31.
     View PubMed
132. Pulido JS, Dalvin LA, Olsen TW, Mano F, Yu M, Shields CL. Peripheral retinal nonperfusion using widefield imaging with von Hippel-Lindau disease. Int J Retina Vitreous. 2018; 4:36 Epub 2018 Oct 03
     View PubMed
133. Dalvin LA, Damento GM, Yawn BP, Abbott BA, Hodge DO, Pulido JS. Parkinson Disease and Melanoma: Confirming and Reexamining an Association. Mayo Clin Proc. 2017 Jul; 92 (7):1070-1079
     View PubMed
134. Adeyemo O, Jeter PE, Rozanski C, Arnold E, Dalvin LA, Swenor B, Dagnelie G, PLoVR Study Group. Living with Ultra-Low Vision: An Inventory of Self-Reported Visually Guided Activities by Individuals with Profound Visual Impairment. Transl Vis Sci Technol. 2017 May; 6 (3):10 Epub 2017 May 31
     View PubMed
135. Dalvin LA, Smith WM. Intraocular manifestations of mycobacterium tuberculosis: A review of the literature. J Clin Tuberc Other Mycobact Dis. 2017 May; 7:13-21 Epub 2017 Feb 17
     View PubMed
136. Dalvin LA, Pulido JS, Marmorstein AD. Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States. Ophthalmic Genet. 2017 Mar-Apr; 38 (2):143-147 Epub 2016 Apr 27
     View PubMed
137. Dalvin LA, Fervenza FC, Sethi S, Pulido JS. SHEDDING LIGHT ON FUNDUS DRUSEN ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: BREAKING STEREOTYPES OF TYPES I, II, AND III. Retin Cases Brief Rep. 2016 Winter; 10 (1):72-8
     View PubMed
138. Dalvin LA, Garcia MD, Salomão DR, Iezzi R, Barkmeier AJ. Necrotizing Subconjunctival Granulomata and Intraoperative Use of Topical GenTeal Gel. Ophthalmology. 2016 Oct; 123(10):2262-3. Epub 2016 Jun 17.
     View PubMed
139. Dalvin LA, Smith WM. Orbital and external ocular manifestations of Mycobacterium tuberculosis: A review of the literature. J Clin Tuberc Other Mycobact Dis. 2016 Aug; 4:50-57 Epub 2015 Nov 27
     View PubMed
140. Dalvin LA, Fervenza FC, Sethi S, Pulido JS. Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series. Ophthalmology. 2016 Jul; 123 (7):1588-94 Epub 2016 Mar 18
     View PubMed
141. Dalvin LA, Abou Chehade JE, Chiang J, Fuchs J, Iezzi R, Marmorstein AD. Retinitis pigmentosa associated with a mutation in BEST1. Am J Ophthalmol Case Rep. 2016 Jul; 2:11-17. Epub 2016 Mar 30.
     View PubMed
142. Dalvin LA, Thom SB, Garcia JJ, Fadel HJ, Baratz KH. Scleritis Due to Histoplasmosis. Cornea. 2016 Mar; 35: (3)402-4.
     View PubMed
143. Dalvin LA, Johnson AA, Pulido JS, Dhaliwal R, Marmorstein AD. Nonantibestrophin Anti-RPE Antibodies in Paraneoplastic Exudative Polymorphous Vitelliform Maculopathy. Transl Vis Sci Technol. 2015 May; 4 (3):2 Epub 2015 May 15
     View PubMed
144. Dalvin LA, Fautsch MP. Analysis of Circadian Rhythm Gene Expression With Reference to Diurnal Pattern of Intraocular Pressure in Mice. Invest Ophthalmol Vis Sci. 2015 Apr 1; 56(4):2657-63.
     View PubMed
145. Sweiss RB, Shweikeh F, Sweiss FB, Zyck S, Dalvin L, Siddiqi J. Suprasellar mature cystic teratoma: an unusual location for an uncommon tumor. Case Rep Neurol Med. 2013; 2013:180497 Epub 2013 Oct 02
     View PubMed